Elevation Wealth Partners’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.32K Buy
97
+71
+273% +$1.14K ﹤0.01% 1287
2026
Q2
$534 Hold
26
– – ﹤0.01% 1281
2026
Q1
$573 Buy
+26
New +$453 ﹤0.01% 1035

Other funds holding CC

Elevation Wealth Partners's CC Position: Q3 2026 in Review

Elevation Wealth Partners increased its Chemours (CC) stake by 273% in Q3 2026, buying an estimated $1.14K and bringing the position to 97 shares worth $1.32K. The position accounts for ﹤0.01% of the portfolio, ranked #1287.

Elevation Wealth Partners first reported a position in CC in Q1 2026 and has held it in 3 quarters since. 143 funds tracked by Wall St. Rank hold CC as of Q3 2026.

  • Elevation Wealth Partners held 97 shares of Chemours worth $1.32K as of Q3 2026.
  • Elevation Wealth Partners bought 71 Chemours shares in Q3 2026, an estimated $1.14K.
  • Chemours made up ﹤0.01% of Elevation Wealth Partners's portfolio in Q3 2026, its #1287 holding.
  • Elevation Wealth Partners first reported a position in Chemours in Q1 2026 and has held it in 3 quarters since.
  • 143 funds tracked by Wall St. Rank held Chemours as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.